All regulations
Nonrulemaking
FDA
FDA-2019-P-1800
Requests Commissioner of FDA to take all administrative actions required for reclassification of medical devices associated with Product Code NCD; reclassification of Product Code NCD from Class III to Class II subject to 510k pre-market notification
Documents
13
Comments
0
Description
CLOSED
Key Dates
Comment Period OpensApr 15, 2019
Documents
| Type | Title | Status |
|---|---|---|
Other |
Keywords
Boditech Med Inc.
Reclassification
Class III
Class II
Product Code NCD
Test
Immunity
Cell Mediated
Mycobacterium Tuberculosis
Data from Regulations.gov